Pediatric Phase 1 Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors ADVL1115: A Children's Oncology Group Phase 1 Consortium Report
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2882
Full Text
Open PDFAbstract
Available in full text
Date
July 27, 2017
Authors
Publisher
American Association for Cancer Research (AACR)